
Outcomes Research
Articles
-
Jan 14, 2025 |
jamanetwork.com | Kristine Ensrud |Outcomes Research |Carolyn Crandall |Susan Marie Ott
Fracture Risk Assessment as a Component of Osteoporosis Screening—Easier Said Than Done US Preventive Services Task Force USPSTF Recommendation: Screening for Osteoporosis to Prevent Fractures US Preventive Services Task Force; Wanda K. Nicholson, MD, MPH, MBA; Michael Silverstein, MD, MPH; John B. Wong, MD; David Chelmow, MD; Tumaini Rucker Coker, MD, MBA; Esa M.
-
Jan 14, 2025 |
newswise.com | Outcomes Research
“Health technology assessment (HTA) guidelines are intended to support successful implementation of HTA by enhancing consistency and transparency in concepts, methods, processes, and use, thereby enhancing the legitimacy of the decision-making process,” said c author Manit Sittimart, MSc, Health Intervention and Technology Assessment Program (HITAP), Ministry of Public Health, Nonthaburi, Thailand.
-
Dec 18, 2024 |
newswise.com | Outcomes Research
Lawrenceville, NJ, USA—December 18, 2024—Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced today the publication of a special themed section of research papers that document challenges in rare disease evidence and economic evaluation and policy as well as ways in which the environment is evolving to address them.
-
Dec 10, 2024 |
newswise.com | Outcomes Research
Healthcare systems around the world are facing a number of momentous issues that make it challenging to identify which healthcare decisions will lead to the best health outcomes for patients. Strained budgets, the growth of innovative new therapy options, and rising costs all contribute to the increasing complexity of healthcare decision making.
-
Dec 5, 2024 |
genomebiology.biomedcentral.com | Carlos Moran |Carlos Morán |Paola Ramos |Outcomes Research |Yamila Caraballo
Each patient-tumor sample had a 1-mm sample obtained from a region of tumor and stroma near the respective tumor-stroma interface. SMI was obtained on 3 tissue microarrays (TMAs) using the Human Immuno-Oncology Panel (consisting of 978 RNA probes). Between stromal and tumor primary-disease fields of view (FOV), 40 FOV passed the applied quality filters (see Methods, Table 1, Additional File 1: Fig. S1, Additional File 2: Table S1.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →